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Abstract
Higher scores on the personality trait of neuroticism, the tendency to experience negative emotions, are associated with
worse mental and physical health. Studies examining links between neuroticism and health typically operationalize
neuroticism by summing the items from a neuroticism scale. However, neuroticism is made up of multiple heterogeneous
facets, each contributing to the effect of neuroticism as a whole. A recent study showed that a 12-item neuroticism scale
described one broad trait of general neuroticism and two special factors, one characterizing the extent to which people worry
and feel vulnerable, and the other characterizing the extent to which people are anxious and tense. This study also found that,
although individuals who were higher on general neuroticism lived shorter lives, individuals whose neuroticism was
characterized by worry and vulnerability lived longer lives. Here, we examine the genetic contributions to the two special
factors of neuroticism—anxiety/tension and worry/vulnerability—and how they contrast with that of general neuroticism.
First, we show that, whereas the polygenic load for neuroticism is associated with the genetic risk of coronary artery disease,
lower intelligence, lower socioeconomic status (SES), and poorer self-rated health, the genetic variants associated with high
levels of anxiety/tension, and high levels of worry/vulnerability are associated with genetic variants linked to higher SES,
higher intelligence, better self-rated health, and longer life. Second, we identify genetic variants that are uniquely associated
with these protective aspects of neuroticism. Finally, we show that different neurological pathways are linked to each of
these neuroticism phenotypes.
Introduction
Neuroticism is one of the ﬁve higher-order factors of per-
sonality, and is consistently identiﬁed in dimensional
models of personality [1]. Neuroticism largely describes the
tendency to experience negative emotions, and individual
differences in neuroticism show moderate to high stability
across much of the adult life course [2]. Higher neuroticism
is associated with a greater risk of psychiatric disorders
[3–5], and some studies link higher levels of neuroticism to
an increase in all-cause mortality [6]. High neuroticism has
been estimated to have an economic burden to society
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greater than that of substance abuse, mood disorders, or
anxiety disorders [7].
Like other traits, such as height [8] or intelligence [9],
neuroticism is heritable [10]. Twin and family estimates
indicate that around 48% of phenotypic variance can be
explained by genetic effects [11]. A subset (summing to a
h2SNP of 4–15% [10, 12]) of this heritability can be traced to
genetic variants in linkage disequilibrium (LD) with geno-
typed common single nucleotide polymorphisms (SNPs),
using genomic-relatedness-matrix restricted maximum
likelihood single component (GREML-SC) analyses.
However, heritability estimates derived using GREML-SC
represent a lower bound for the genetic effects that can be
measured using SNP data. This was shown for neuroticism
by Hill et al. [10] who found that, by including the variance
explained by genetic variants in poor LD with genotyped
SNPs, using GREML-KIN [13], heritability from DNA
analysis increased to 30%. Despite the large contributions to
phenotypic variance that rarer variants and non-SNP genetic
variation appear to make to individual differences in neu-
roticism [10], it is the common SNPs that appear to act
across neuroticism, psychiatric disorders, and physical dis-
ease [14]. Understanding the common genetic contributions
to neuroticism, therefore, has the potential to offer insight
into the causes of psychiatric disorders, health, and
longevity.
Genome-wide association studies (GWAS) have begun
to identify loci that are associated with neuroticism [15, 16],
with well powered replication studies also being conducted
[17], as well as ﬁnding loci that display a shared association
between neuroticism and psychiatric disorders [18]. How-
ever, these studies derive a neuroticism variable by sum-
ming scores on all the items of a neuroticism scale. This
scoring method treats each item in the neuroticism scale
equally, and error variance will also be included in the
score, potentially resulting in a reduction of power in an
analysis. Furthermore, should this sum-score method be
used on a subset of neuroticism scale items to try and derive
scores that correspond to speciﬁc aspects, or “clusters”, of
neuroticism [19], each of the scores will be highly corre-
lated with one another because of their associations with the
general factor of neuroticism [20]. Consequently, it is
impossible to determine whether a link between an outcome
and a sum score, representing a different aspect of neuro-
ticism, reﬂect associations between the outcomes and that
speciﬁc aspect, or between the outcome and the general
factor of neuroticism [20].
Hierarchical clustering analysis has been applied to
genetic correlations between the neuroticism items in the
Short-scale Eysenck Personality Questionnaire-Revised
[21], in an attempt to identify genetically distinct clusters
of neuroticism. This technique was used to identify groups
of items that showed stronger genetic correlations with each
other than with other items [19]. Cluster scores were then
derived by summing the scores from these genetically more
similar items to form one phenotype called “Worry” (con-
sisting of the items “Would you call yourself a nervous
person?”, “Are you a worrier?”, “Would you call yourself
tense or ‘highly strung’?”, and “Do you suffer from
‘nerves’?”) and a second phenotype called “Depressed
affect” (consisting the items “Do you often feel lonely?”,
“Do you ever feel ‘just miserable’ for no reason?”, “Does
your mood often go up and down?”, and “Do you often
feel ‘fed-up’?”) [19]. However, due to the presence of a
strong general factor of neuroticism in the Short-scale
Eysenck Personality Questionnaire-Revised (Supplemen-
tary Table 1a & Supplementary Table 1b), sum scores will
be correlated with one another and with the general factor.
The result of such contamination is that the clusters, derived
to be genetically homogenous, will still necessarily show
strong genetic correlations with a sum-score derived general
neuroticism variable, due to the variance shared across the
12 items, as can be seen in Nagel et al. [19].
In the present study, rather than using hierarchical clus-
tering analysis and operationalizing the clusters as sum
scores [19], we used a latent variable method—a bifactor
exploratory structural equation model [22] (Supplementary
Table 1a & Supplementary Table 1b) shown in Fig. 1—to
identify a general factor, and two special factors of neuro-
ticism for 401,674 UK Biobank participants who completed
all 12 neuroticism items from the Short-scale Eysenck
Personality Questionnaire-Revised [21]. In contrast to
summing the scores from subsets of items to represent a
neuroticism phenotype, a bifactor model extracts a single
general factor from the variance that is common across all
the items, as well as extracting additional factors that
represent the degree to which the data depart from what
would be expected if only a single general factor were
present (Fig. 1) [22, 23]. Consequently, unlike Nagel et al.’s
[19] sum scores, the special (non-general) neuroticism
factors from a bifactor model are not ‘contaminated’ with
variance that is common across all items.
Gale et al. previously used a bifactor model and identi-
ﬁed two special neuroticism factors—worry/vulnerability
and anxiety/tension—from the 12 neuroticism items making
up the Short-scale Eysenck Personality Questionnaire-
Revised [6]. They estimated factor scores to represent
these special neuroticism factors and the general neuroti-
cism factor, which sometimes had different associations
with mortality: higher scores on the general neuroticism
factor were associated with increased mortality from all
causes and higher scores on the worry/vulnerability special
factor were related to signiﬁcantly decreased mortality from
all causes [6].
In the current study, we sought to further this work by
examining the genetic contributions to the worry/
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vulnerability and anxiety/tension special factors of neuro-
ticism that Gale et al. identiﬁed previously [6]. We examine
whether these special factors contrast with the genetic
aetiology of a general factor of neuroticism, with which
they are uncorrelated, and how the general factor and two
special factors overlap genetically with mental and physical
health.
Method
Samples
Participants were members of the UK Biobank study
(http://www.ukbiobank.ac.uk) [24]. UK Biobank consists of
502,655 participants who were recruited between the years
of 2006 and 2010 from the United Kingdom and were
between the ages of 39 and 73 years (mean 56.9, SD= 8.0
years). Each participant provided detailed information per-
taining to their background, lifestyle, and took part in
cognitive and physical testing; blood, urine, and saliva
samples were also provided and stored. The Research Ethics
Committee granted ethical approval for the study—refer-
ence 11/NW/0382—and the current analyses were con-
ducted under data application 10279.
Phenotype measurement
Neuroticism was assessed using the 12 questions (e.g.,
“Does your mood often go up and down?” all items can be
found in Supplementary Table 1) from the Short-scale
Eysenck Personality Questionnaire-Revised [21]. UK Bio-
bank participants were administered these items using
touchscreens and were instructed to “Work quickly and do
not think about the exact meaning of the question.” Parti-
cipants were asked to choose one of four responses for each
question: “Yes” (coded 1), “No” (coded 0), “Do not know”
(coded—1) and “Prefer not to answer” (coded—3). Of the
502,655 UK Biobank participants, 100,981 did not answer
“Yes” or “No” to all 12 questions, and so were excluded
from further analyses.
Genotyping and quality control
Details of the procedures used in the genotyping of the UK
Biobank are available elsewhere [25]. In brief, two custom
genotyping arrays were used to genotype 49,950 partici-
pants (UK BiLEVE Axiom Array) and 438,427 participants
(UK Biobank Axiom Array), respectively [25, 26]. Geno-
type data on 805,426 markers were available for 488,377 of
the participants in UK Biobank. Imputation was performed
using a combination of the Haplotype Reference Con-
sortium (HRC) reference panel, 1000 genomes, and
UK10K. As advised by UK Biobank, we restricted the
imputation analysis to the HRC panel. This led to
39,131,578 autosomal SNPs, after imputation, being avail-
able for the 270,059 participants who had completed all 12
neuroticism items [25]. Allele frequency checks [27] were
performed against the HRC [28] and 1000G [29] site lists,
and variants were removed if the allele frequencies differed
from the reference set by more than +/− 0.2.
Additional quality control was implemented in the data
used in the present study, and included the removal of
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Fig. 1 Illustrates a bifactor model applied to the 12 neuroticism items.
As can be seen the use of a bifactor model results in variance that was
common across the 12 items being extracted to form a general factor of
neuroticism, labelled “General Neuroticism” here. Two special factors
were also identiﬁed that were unrelated to the variance allocated to the
general factor of neuroticism. These two special factors are labelled
“Anxiety/Tension” and “Worry/Vulnerability”. Thus, the advantage
afforded through the use of a bifactor model over the sum-score
method such as those used by Nagel et al. [19] is that additional factors
will not contain variance that is common across each of the 12 items.
This allows for the discovery of the genetic associations with special
(non-general) neuroticism factors that might be distinct from those
with the general factor. The ﬁgure shows only those items that load
most strongly on the Anxiety/Tension and Worry/Vulnerability special
factors. Path coefﬁcients for the bifactor model are shown in Sup-
plementary Table 1a
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participants with non-British ancestry (identiﬁed by Bycroft
et al. [25] by performing a principal component analysis on
the genotyped SNP data to remove ethnic outliers from a
subset of the UK Biobank participants who self-identiﬁed as
White British) as well as those who had an extreme score
based on heterozygosity (extreme scores were deﬁned as
those with a principal component-adjusted heterozygosity
score above 0.19 as shown by Bycroft et al. [25]) and >5%
missingness [25]. Individuals were also removed if their
reported sex was inconsistent with genetically inferred sex,
as were individuals with neither XX nor XY chromosomes.
Finally, individuals with more than 10 putative third degree
relatives (identiﬁed by Bycroft et al. [25] by estimating the
kinship coefﬁcients for all pairs of samples using the soft-
ware KING [30]) were also removed. This left 408,095
individuals. Using GCTA [31] on 131,790 reportedly-
related participants [31, 32] one from each pair of related
individuals was removed using a genetic relationship
threshold of 0.025, resulting in 332,050 individuals. Fol-
lowing these quality control steps, a sample size of 270,059
individuals had both genetic data and had answered all 12
neuroticism items. SNPs with a minor allele frequency
(MAF) <0.0005, and an imputation quality score <0.1 were
removed along with multi-allelic SNPs, resulting in
18,485,882 autosomal SNPs.
Statistical analysis
Exploratory bifactor analysis of neuroticism items
For the 401,674 participants who answered “yes” or “no” to
all 12 neuroticism items, like Gale et al. [6], we used Mplus
version 8.2 [33] to obtain estimates of three latent bifactor
scores for each participant. To do so we ﬁrst conducted an
exploratory bifactor analysis. This involved using explora-
tory structural equation modelling analysis to extract
the three factors and then applying an oblique bifactor
Geomin rotation to the resulting 12 × 3 factor loading
matrix [22, 23].
A Geomin rotation of a p × k factor loading matrix Λ is
one in which correlated axes are rotated to minimize the
criterion:
geomin Λð Þ ¼
Xp
i¼1
Yk
r¼1
λ2ir þ ε
 
 !1
k
where p refers to the row, k refers to the column, λ is the
loading of a factor on an item, and ε= 0.01 [34]. The
criterion is thus at its minimum when every item loads on
one single factor. In the bifactor case, this criterion is
applied only to the last k-1 factors, so that the criterion is
minimized when each item loads on only one of these
factors.
The bifactor model showed evidence of good model ﬁt:
the root mean square error of approximation was 0.048
(90% CI= 0.048–0.049), the comparative ﬁt index was
0.975, the Tucker Lewis index was 0.951, and the stan-
dardized root mean square residual was 0.019. The factor
loadings are presented in Supplementary Table 1a and
Supplementary Table 1b (The correlation matrix can be
found in Supplementary File 1). The ﬁrst factor, which
explained 29% of the variance, was a general factor of
neuroticism onto which all 12 items loaded. The second and
third factors extracted were special factors and so are
uncorrelated with the general factor. The second factor was
characterized by loadings on the items in the neuroticism
scale of “Would you call yourself a nervous person?”
(loading of 0.60), “Do you suffer from ‘nerves’?” (loading
0.49), and “Would you call yourself tense or ‘highly
strung’?” (loading of 0.35). Due to each of these neuroti-
cism items describing feeling tense or anxious we called this
residual variance the anxiety/tension special factor of neu-
roticism. As special factors are uncorrelated with the var-
iance in the general factor of neuroticism the special factor
of anxiety/tension can be considered what is left of anxiety/
tension following the removal of the general factor of
neuroticism. The third factor was characterized by loadings
on the items in the neuroticism items of “Do you worry too
long after an embarrassing experience?” (loading of 0.57),
“Are your feelings easily hurt?” (loading of 0.40), “Are you
a worrier?” (loading of 0.31), and “Are you often troubled
by feelings of guilt?” (loading of 0.31). As each of these
neuroticism items describes feelings of being vulnerable or
ruminating and worrying, we called the residual variance
that is common across these three items the worry/vulner-
ability special factor of neuroticism. This special factor of
worry/vulnerability can be considered what is left of worry/
vulnerability following the removal of the general factor of
neuroticism. The correlations between the general factor
and each of the two special factors was deﬁned as zero in
the model; the correlation between the two special factors in
the model was r= 0.311 (SE= 0.006, 95% CI= [0.301,
0.321], P < 0.0001). As in Gale et al. [6], the relationship
between these two aspects of neuroticism was not attribu-
table to variance from the general factor of neuroticism, as
indicated by a correlation of zero between each of the
special factors with the general factor [35].
The special factors accounted for 7 and 6% of the var-
iance, respectively, and their salient loadings, that is those
greater than 0.3, ranged from 0.310 to 0.604
(median= 0.403). These special factors were thus modestly
well deﬁned. A prior analysis by Weiss et al. (2019)
[36] found that the general factor and both the anxiety/
tension and worry/vulnerability special factors clearly
replicated (congruence coefﬁcients= 1.00, 1.00, and 0.98,
respectively) in the 1,434 participants used to develop the
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Short-scale Eysenck Personality Questionnaire-Revised
[21]. Weiss et al. [36] also found that these factors mostly
replicated in a subsample of 8,158 participants from the
Generation Scotland: Scottish Family Health Study (GS:
SFHS) cohort [37, 38] (congruence coefﬁcients= 0.99,
0.93, and 0.99, respectively). Of note is that the subsample
of GS:SFHS used in Weiss et al. [36] is of greater size than
the unrelated sample used in the current study to conduct
the genetic analysis.
Genome-wide association analysis (GWAS) in the UK
Biobank sample
The score on the general factor and both special factors
were adjusted for age, sex, assessment centre, genotype
batch, array, and 40 genetic principal components derived
from genotyped SNPs. Association analysis was performed
separately for each of the three neuroticism phenotypes
using an additive model implemented using BGENIE [25].
Linkage disequilibrium score regression
Univariate Linkage disequilibrium score (LDSC) regression
[39] was used to derive a SNP-based heritability estimate
for each of the three neuroticism factors, as well as to
quantify the amount of residual stratiﬁcation in each data
set. Bivariate LDSC regression was used to derive genetic
correlations [40] with other phenotypes.
Genetic correlations derived using LDSC are informative
of the shared genetic aetiology between two traits. They can
be interpreted as the degree to which the heritable variation
of two traits is correlated, and so do not describe the
absolute magnitude of the effect on the phenotype created
by this overlap. For example, two traits could have a very
low, but non-zero, heritability, and still show a very high
genetic correlation. In this instance, the interpretation would
be that, whereas genetic effects explain only a negligible
portion of phenotypic variance for each trait, as evidenced
by the low heritability of each trait, the genetic effects that
explain variance in one trait, are largely the genetic effects
that explain phenotypic variance in the second trait, as
evidenced by the high genetic correlation between the two
hypothetical traits. In addition, providing the phenotypic
correlation between two traits is not zero, the magnitude of
the phenotypic correlation between traits is not an indicator
of the magnitude of the genetic correlation between the
same traits. For example, two traits may have a very low
phenotypic correlation with each other but have a very high
genetic correlation. For example, the genetic correlations
between the 12 items of the Short-scale Eysenck Personality
Questionnaire-Revised [21] in Nagel et al. (2018) [19] are
far larger than their phenotypic correlations. In this instance,
the interpretation would be that, whereas these traits share
very little variance with each other, as evidenced by the low
correlation, the variance that is genetic in origin is largely
shared across these traits, as evidenced by the large genetic
correlation.
A MAF cut-off of <0.01 was applied. Only SNPs that
were in HapMap 3 with MAF >0.05 in the 1000 Genomes
EUR reference sample were included. Next, indels and
structural variants were removed as were strand ambiguous
variants. SNPs whose alleles did not match those in the
1000 Genomes were also removed. The presence of outliers
can increase the standard error in LD score regression [40],
and so SNPs with a χ2 > 80 were removed. LD scores and
weights for use with European populations were down-
loaded from (http://www.broadinstitute.org/~bulik/eur_
ldscores/). Because we tested 32 genetic correlations
(Alzheimer’s disease was included twice) against each of
the three neuroticism factors, we controlled for the false
discovery rate (FDR) using the Benjamini–Hochberg [41]
procedure. Full details of each of these GWAS along with
links (where possible) to the data used can be found in
Supplementary Table 2.
Identiﬁcation of independent genomic loci and functional
annotation
Genetic loci related to each of the three factors of neuroti-
cism were identiﬁed using Functional Mapping and anno-
tation of genome-wide association studies (FUMA, http://
fuma.ctglab.nl/) First, independent signiﬁcant SNPs were
identiﬁed on the basis of their P-value being genome-wide
signiﬁcant (P < 5 × 10−8), and being independent from each
other (r2 < 0.6) within a 1mb window. Second, SNPs that
were in LD with the independent lead SNPs (r2 ≥ 0.6) within
a 1mb window, and in the 1000 genomes reference panel
with a MAF greater than 0.0005, were included for further
annotation. Third, lead SNPs were identiﬁed using the
independent signiﬁcant SNPs deﬁned as above. Lead SNPs
were a subset of the independent signiﬁcant SNPs that were
in LD with each other at r2 < 0.1, again with a 1mb window.
Fourth, genomic risk loci were identiﬁed by merging lead
SNPs if they were closer than 250 kb apart, meaning that a
genomic risk locus could contain multiple independent
signiﬁcant SNPs and multiple lead SNPs. Finally, all SNPs
in LD of r2 ≥ 0.6 with one of the independent signiﬁcant
SNPs formed the border, or edge, of the genomic risk loci.
To map LD, the 1000 genomes phase 3 was used [42].
Functional annotation of each of the three neuroticism
factors was carried out in FUMA (http://fuma.ctglab.nl/)
using all SNPs found within the independent genomic loci
that were in LD of r2 ≥ 0.6, were nominally signiﬁcant, and
had a MAF of ≥0.0005. To assess the functional con-
sequences of genetic variation at these SNPs, they were ﬁrst
matched based on chromosome, base pair position,
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reference, and non-reference alleles to a database containing
functional annotations including the Annotate Variation
(ANNOVAR) categories [43], Combined Annotation
Dependent Depletion (CADD) scores [44], Regulome
Database (RDB) scores [45], and chromatin states [46–48].
ANNOVAR [43] categories were used to identify the
function of the SNP and to locate their position. A CADD
score is a continuous measure that is used to assess how
deleterious genetic variation at the SNP is to protein
structure and function. Higher CADD scores are indicative
of a more deleterious variant, with scores of greater than
12.37 providing evidence of pathogenicity [44]. RDB
scores are categorical measures created using data from
expression quantitative trait loci (eQTLs) as well as chro-
matin marks. RDB scores range from 1a to 7 with lower
scores indicating greater evidence for the variant having a
regulatory function.
Chromatin states can be used to predict transcription/
regulatory effects at SNP loci. This was described using a
15-point scale for each variant using a hidden Markov
model based on ﬁve chromatin marks for 127 epigenomes
in the Roadmap Epigenomics Project [47]. The lower the
chromatin score the greater the level of accessibility to the
genome at this site, indicating open chromatin sites, with
scores of less than 8 indicative of an open chromatin region.
The minimum chromatic state across tissues was used.
Gene-mapping
Three techniques were used to link the association found in
the independent genomic loci to genes. First, SNPs were
mapped to genes based on physical distance. For this
positional mapping technique, SNPs within a 10kb window
from the known protein genes found in the human reference
assembly (hg19) were included.
Second, eQTL mapping was carried out. Here, SNPs
were mapped to genes if allelic variation at the SNP is
associated with expression levels of the gene. For eQTL
mapping, information on 45 tissue types from three data
bases (GTEx, Blood eQTL browser, and BIOS QTL
browser) based on cis-QTLs where SNPs are mapped to
genes up to 1Mb away. An FDR of 0.05 was used as a cut-
off to deﬁne signiﬁcant eQTL associations.
Finally, chromatin interaction mapping was performed.
SNPs were mapped to genes if there was a three-
dimensional DNA–DNA interaction between the SNP
region indicated by the independent genomic loci, with the
gene region. No distance boundary was used as chromatin
interactions can involve long-range interactions between
SNPs with genes. Hi-C data of 14 tissue types were used for
chromatin interaction mapping [49]. Chromatin interactions
can span multiple genes, due to SNPs being located in
regions that interact with other regions that also contain
multiple genes. To both reduce the number of genes map-
ped, and to increase the likelihood that those mapped are
those that are biologically relevant to the independent
genomic loci, we selected only interaction mapped genes
where one region involved with the interaction overlapped
with a predicted enhancer region in any of the 111 tissue/
cell types found in the Roadmap Epigenomics Project [47],
and the other region was located in a gene promoter region
(250bp upstream and 500bp downstream of the transcrip-
tion start site and also predicted to be a promoter region by
the Roadmap Epigenomics Project [47]). We used an FDR
of 1 × 10−5 to deﬁne a signiﬁcant interaction.
Gene-based association analysis
Gene-based analysis was conducted using Multi-marker
Analysis of GenoMic Annotation (MAGMA) [50]. SNPs
from the summary statistics from each of the three neuro-
ticism phenotypes were matched to genes according to the
NCBI 37.3 build with gene boundaries being deﬁned as
the stop and start site. To model linkage disequilibrium the
reference panel from the 1000 Genomes (phase 1, release 3)
was used. This led to 18,330 autosomal genes being
available for analysis. To control for multiple testing, a
Bonferroni correction was used resulting in an alpha level
of 2.728 × 10−6 for the three phenotypes.
Gene-set analysis
Using MAGMA [50], gene-set analysis was conducted
using competitive testing. A total of 10,894 gene-sets,
which were sourced from Gene Ontology [51], Reactome
[52], the Molecular Signatures database (MSigDB) [53],
and other sources, were examined for enrichment in each of
the three factors of neuroticism. A Bonferroni correction
was applied to control for the multiple tests performed on
the 10,894 gene sets.
Gene-property analysis
To examine the importance of particular tissue types rele-
vant to the neuroticism factors, a gene-property analysis
was conducted using MAGMA. This analysis was used to
determine if, in 30 broad tissue types, and 53 speciﬁc tis-
sues, tissue-speciﬁc differential expression levels were
predictive of the association of a gene with each of the three
factors of neuroticism. Tissue types were taken from
the GTEx v7 RNA-seq database [54] with expression values
being log2 transformed with a pseudocount of 1 after
winsorizing at 50 with the average expression value being
taken from each tissue. Multiple testing was controlled for
using Bonferroni correction for 30, and 53 tests. A separate
gene-property analysis was used to determine if
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transcription in the brain at any one of 11 developmental
stages [55], or across 29 different ages [55], was associated
with a gene’s link to each of the factors of neuroticism. A
Bonferroni correction was used to control for 11 and 29
tests separately.
Genetic prediction
Genetic prediction was conducted with two goals. First, to
examine if the polygenic signal associated with the general
factor of neuroticism, and each of the two special factors,
replicated in an independent sample. Second, to assess if
unlike the general factor of neuroticism, those with a greater
polygenic burden for higher levels of the special factor of
anxiety/tension, and the special factor of worry/vulnerability,
have greater level of phenotypic income and intelligence, as
would be expected from the genetic correlation analysis.
Polygenic risk scores (PGRS) were derived using PRSice-2
[56] (https://choishingwan.github.io/PRSice/) and the GS:
SFHS cohort [37, 38].
The recruitment protocol and sample characteristics of
GS:SFHS are described in full elsewhere [37, 38]. In brief
for GS:SFHS, 23,690 participants were recruited through
their GP from across Scotland. Participants were all aged 18
and over and were not ascertained based on the presence of
any speciﬁc disease.
Neuroticism was measured in GS:SFHS using the Short-
scale Eysenck Personality Questionnaire-Revised [21].
Participants were omitted if they did not answer one or
more of the 12 neuroticism items, or if they had also taken
part in UK Biobank. Finally, participants were removed
from the analysis in the event that they were related to
another member of GS:SFHS at 0.025 as ascertained using
a genomic relationship matrix derived using GCTA [31].
For all phenotypes examined, SNPs were included in the
data if they had a MAF ≥ 0.01 and Hardy-Weinberg P-value
of 0.000001 and individuals who had taken part in UK
Biobank were also removed from the GS:SFHS data set
(n= 174).
As conducted in UK Biobank and Gale et al. [6] for the
remaining 6907 participants of GS:SFHS, Mplus version
8.2 [33] was used to carry out an exploratory structural
equation model with an oblique bifactor Geomin rotation
[22, 23]. Again three scores were derived for each partici-
pant. The bifactor model for GS:SFHS is presented in
Supplementary Table 1a and 1b (the correlation matrix can
be found in Supplementary File 2). Using GS:SFHS there
was evidence of a general factor which each of the 12 items
loaded on. This factor was nearly identical to its counterpart
in the structure derived from UK Biobank (congruence
coefﬁcient= 0.98).
The same second factor as identiﬁed in UK Biobank
(anxiety/tension special factor of neuroticism) was also
identiﬁed in GS:SFHS. This second factor was character-
ized by loading on the items of “Would you call yourself a
nervous person?” (loading of 0.378), “Do you suffer from
‘nerves’?” (loading of 0.315), and “Would you call yourself
tense or ‘highly strung’?” (loading of 0.198) from the
neuroticism scale. This similarity between this factor and its
counterpart in the structure derived from UK Biobank
(congruence= 0.84) fell just short of the level (0.85) [57]
leading one to conclude that the factors were similar.
The special factor of worry/vulnerability was also
identiﬁed in GS:SFHS. This third factor was again char-
acterized by loadings on the items in the neuroticism
items of “Do you worry too long after an embarrassing
experience?” (loading of 0.564), “Are your feelings easily
hurt?” (loading of 0.403), “Are you a worrier?” (loading
of 275), and “Are you often troubled by feelings of guilt?”
(loading of 0.328). The general factor and each of the two
special factors were aligned so that a greater score on each
is indicative of a greater level of the general factor, the
anxiety/tension special factor, and the worry/vulnerability
special factor. This factor was nearly identical to its
counterpart in the structure derived from UK Biobank
(congruence coefﬁcient= 0.99).
For household income a total of 6,680 participants were
available from GS:SFHS who had both phenotypic and
genetic data, and who were unrelated at 0.025. Income was
assessed in GS:SFHS by 6-point scale (1 less than £10,000,
2 between £10,000 and £30,000, 3 between £30,000 and
£50,000, 4 between £50,000 and £70,000, 5 more than
£70,000, and 6 prefer not to answer). Individuals who
preferred not to answer were excluded from the analy-
sis. For intelligence a total of 7,261 participants from GS:
SFHS contributed data on a general factor of intelligence
derived in the same manner as previously reported
[10]. This general factor of intelligence was derived by
extracting the ﬁrst principal component from four cognitive
tests that accounted for 42.3% of the variance in the total
sample. The four tests used were the Mill Hill Vocabulary
Scale, the Wechsler Digit Symbol Substitution Task, the
Wechsler Logical Memory tests, and the phonemic verbal
ﬂuency test.
Each participant’s phenotypic score was then used as a
predictor in a regression analysis with age, sex, and 20
principal components included to control for population
stratiﬁcation in GS:SFHS. The standardized residuals
from this model were then used as each participant’s
phenotype. For each phenotype combination examined,
PRSice-2 was used to create ﬁve PGRS corresponding to
one of ﬁve P-value cut offs (P ≤ 0.01, P ≤ 0.05, P ≤ 0.1,
P ≤ 0.5, P ≤ 1) applied to the association statistics from the
summary data. The polygenic risk scores were then
standardized and used in a regression model for pheno-
type prediction in GS:SFHS.
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Results
As described above, the correlation of the general factor and
each of the special factors in the bifactor model was deﬁned
as 0. The correlation between the two special factors was
estimated in the model as r= 0.311. We estimated each
participant’s score on each of the three factors in the
bifactor model of neuroticism. A correlation of the estimates
of the latent score for the general factor scores and the
anxiety/tension special factor scores in UK Biobank was
found to be r= 0.069. A correlation between the general
factor and the worry/vulnerability special factor scores was
also identiﬁed in UK Biobank as r= 0.121,
(P < 2.20 × 10−16). The special factor scores of worry/vul-
nerability and anxiety/tension correlated with each other at
r= 0.427 (P < 2.20 × 10−16) in UK Biobank (Table 1).
Small differences, such as these, between correlations
derived using the factors within the model and correlations
of the participants’ estimated scores on the latent variables
are expected [58].
We estimated the heritability of each of the neuroticism
phenotypes using univariate LDSC regression and showed
a total of 10.7% (SE= 0.49%) of the phenotypic variation
in the general factor of neuroticism is explained by the
additive effects of common genotyped SNPs (Table 1).
This is comparable to the estimate of 10.8% (SE= 0.50%)
and 10.0% (SE= 0.30%) using a sum-score approach also
derived using UK Biobank [15, 16]. The additive effects
of common genotyped SNPs explained 5.7% (SE=
0.32%) and 6.4% (SE= 0.28%) of the variance in
the anxiety/tension and worry/vulnerability special fac-
tors, respectively. The general factor of neuroticism had
a genetic correlation of rg= 0.98 (SE= 0.003, P > 1 ×
10−200) with the sum-score neuroticism [15] phenotype.
The general factor was found to have a positive genetic
correlation with the anxiety/tension special factor, rg=
0.20 (SE= 0.04, P= 2.05 × 10−8), and with the worry/
vulnerability special factor, rg= 0.35, (SE= 0.03, P=
1.48 × 10−32); the two special factors had a strong positive
genetic correlation with each other, rg= 0.66, (SE= 0.02,
P= 5.96 × 10−187) (Table 1).
Loci discovery and annotation of the general factor
of neuroticism and the two special factors
For the general factor of neuroticism, 51 independent loci
were identiﬁed as genome-wide signiﬁcant (Fig. 2a, Sup-
plementary Table 3). A total of 44 of these loci overlapped
with loci identiﬁed using the data from Luciano et al. [15]
analyzed using FUMA [59] with the same settings as those
used in the current study (Supplementary Table 4). A total
of 42 loci overlapped with those identiﬁed by Nagel et al.
[17] who re-analyzed the Luciano et al. [15] data sets
(Supplementary Table 4). These 51 loci were found to
contain an overrepresentation of SNPs found in introns
(49.69%), as well as SNPs found in intergenic regions
(25.15%) with the two next largest categories being ncRNA
intronic (14.67%), and ncRNA exonic (2.26%) (Supple-
mentary Table 3). Evidence was also found that these loci
contained regulatory regions of the genome, indicated by
32.50% of the SNPs in the genomic loci having RDB less
than 2, indicating that genetic variation at this SNP is likely
to affect gene expression (Supplementary Table 3). Finally,
86.49% of the SNPs within the genomic loci had a mini-
mum chromatin state of <8 indicating that they are located
in an open chromatin state, providing additional evidence
that they are located within regulatory regions (Supple-
mentary Table 3).
Using the GWAS catalogue, lead and tagging SNPs from
the 51 loci identiﬁed for the general factor of neuroticism
were examined for overlap with other traits. A total of 42 of
the 51 loci were found to overlap with loci previously
associated with neuroticism [15], as would be expected.
Five loci also showed overlap with educational attainment.
In addition, variations in these 51 loci have been associated
with psychiatric disorders including, autistic spectrum dis-
order (four loci) and schizophrenia (eight loci) (Supple-
mentary Table 5).
For the anxiety/tension special factor, 14 independent
genomic loci were identiﬁed using a threshold of 5 × 10−8
(Fig. 2b, Supplementary Table 6), only one of which phy-
sically overlapped with the general factor of neuroticism
and with neuroticism operationalized using the sum-score
Table 1 Showing the heritability of each factor on the diagonal, with the phenotypic correlations on the lower half, and the genetic correlations on
the upper half. Standard errors displayed in brackets. Heritability and genetic correlations were derived using LDSC regression
General factor of
neuroticism
Anxiety/tension special factor of
neuroticism
Worry/vulnerability special factor of
neuroticism
General factor of neuroticism 11% (0.5%) 0.20 (0.04) 0.35 (0.03)
Anxiety/tension special factor of
neuroticism
0.07 5.7% (0.3%) 0.66 (0.02)
Worry/vulnerability special factor of
neuroticism
0.12 0.43 6.4% (0.3%)
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method [14] (loci 8 on chromosome 8, bp position
10576753–10732050) (Supplementary Table 7). However,
four additional loci associated with the anxiety/tension
special factor of neuroticism overlapped with the sum-
score-derived neuroticism score used in Nagel et al.’s [17]
re-analysis of the Luciano et al. [15] data sets. As with the
A
B
C
Fig. 2 Manhattan plots for the
factors of neuroticism. All
sample sizes were 270,059
participants. The red line
indicates genome-wide
signiﬁcance and the black
indicates suggestive
signiﬁcance. Figure 2a indicates
the general factor of neuroticism
(Blue). Figure 2b the anxiety/
tension special factor (Gold).
Figure 2c the Worry/
vulnerability special factor (Red)
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general factor, these independent loci harbored a greater
proportion of SNPs located in introns (63.0%), and inter-
genic regions (26.9%). Of these SNPs, 31.1% had an RDB
score of less than 2 and 65.8% had a minimum chromatin
value of less than 8 providing further evidence that these
variants are located in regions of the genome that are linked
to gene regulation (Supplementary Table 6). These 14 loci
showed overlap with the loci identiﬁed in previous GWAS
examining carotid intima media thickness (one locus),
coronary artery disease (two loci), white matter lesion
progression (one locus), systolic blood pressure (one locus),
diastolic blood pressure (one locus), HDL cholesterol (two
loci), adiposity traits, weight, and body mass index (ﬁve
loci) (Supplementary Table 8).
A total of ten genome-wide signiﬁcant loci were identi-
ﬁed (Fig. 2c, Supplementary Table 9) for the worry/vul-
nerability special factor. Only one of these loci overlapped
with the loci identiﬁed for the general factor of neuroticism
(locus 9 on chromosome 18, bp position 53210302–
53464917), two overlapped with the sum-score derived
neuroticism variable used by Luciano et al., and three
overlapped with the re-analysis of the Luciano et al. data
sets conducted by Nagel et al. [16]. Only one locus over-
lapped with the anxiety/tension special factor (locus 4 on
chromosome 4, bp position 28519689–28660963) (Sup-
plementary Table 7). The SNPs in these regions were again
found to be predominantly located within introns (46.5%),
and intergenic regions (32.0%). Evidence that the genome-
wide signiﬁcant loci harboured SNPs that were linked to
gene expression was found again where 31.8% of candidate
SNPs had a RDB score of less than 2 and 67.0% had a
minimum chromatin value of less than 8 (Supplementary
Table 9). Using the GWAS catalogue, these 10 independent
genomic loci have previously been linked to, hand grip
strength (1 locus), brain cytoarchitecture (1 locus), coronary
artery disease (1 locus), and chronotype (1 locus) (Supple-
mentary Table 10).
Gene mapping of the general factor of neuroticism
and the two special factors
This section details the genes that were linked to the loci
that were associated with the general factor of neuroticism
and both special factors. Positional mapping aligned the
SNPs from the independent genomic loci associated with
the general factor of neuroticism to 294 genes by using
location, whereas eQTL mapping matched cis-eQTL SNPs
to 329 genes whose level of expression they have been
shown to inﬂuence. Finally, chromatin interaction mapping
annotated SNPs to a total of 478 genes using three-
dimensional DNA–DNA interactions between the SNPs’
genomic regions and close or distant genes (Supplementary
Table 11, Supplementary Figure 1). Collectively these
mapping strategies identiﬁed 742 unique genes, of which
255 were implicated by two mapping strategies and 104
being implicated by all three. Three genes, STARD6,
C18orf54, and CCDC68, implicated using chromatin map-
ping, showed evidence of a chromatin interaction between
two independent genomic risk loci (Supplementary
Table 12). STARD6 (ENSG00000174448) shows interac-
tions in ﬁve tissue types, C18orf54 (ENSG00000166845)
also shows interactions in ﬁve types of tissue, and CCDC68
(ENSG00000166510) shows interactions in four tissues.
Each of these genes interacts with loci 49 and 50. Gene-
based statistics derived in MAGMA indicated a role for 277
genes (Supplementary Table 13), 73 of which overlapped
with genes implicated by all three mapping strategies
(Fig. 3a).
For the anxiety/tension special factor, positional mapping
indicated a role for 69 genes, with eQTL mapping indi-
cating a role for 111 genes. Chromatin interaction mapping
annotated a total of 136 genes (Supplementary Table 14 &
15, Supplementary Figure 2). Across these three mapping
strategies, 222 unique genes were identiﬁed with 70 of these
being implicated by two mapping strategies. A total of 24
unique genes were implicated by all three mapping strate-
gies. MAGMA was also used to indicate a role for 99 genes
(Supplementary Table 16). Fifteen of these genes over-
lapped with those identiﬁed using the three mapping stra-
tegies (Fig. 3b).
Sixteen genes were identiﬁed using positional mapping
for the worry/vulnerability special factor. eQTL mapping
matched cis-eQTL SNPs to 16 genes and 58 genes were
identiﬁed using chromatin interactions between the SNPs’
genomic regions, and close or distant genes (Supplementary
Table 17 & 18, Supplementary Figure 3). For the worry/
vulnerability special factor these mapping strategies impli-
cated 71 unique genes of which 14 were implicated by two
mapping strategies, and ﬁve were implicated by all three.
Using MAGMA, 65 genes were implicated (Supplementary
Table 19), ﬁve of which overlapped with genes implicated
by all three mapping strategies (Fig. 3c).
Cross-trait comparison of implicated genes
Next, we examined the genes implicated by each of the four
methods across the three factors of neuroticism. This ana-
lysis revealed little overlap in the genes implicated as
potentially being causal for each of the three factors. Using
positional mapping, whilst 294 genes were implicated for
the general factor of neuroticism and 69 were implicated for
anxiety/tension only six genes were implicated across both
neuroticism phenotypes. A total of 16 genes were impli-
cated for the worry/vulnerability phenotype with only three
genes overlapping with the 294 implicated for the general
factor. No genes were shared between the anxiety/tension
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special factor and the worry/vulnerability special factor
using positional mapping (Fig. 3d).
Using eQTL mapping, 329 genes were implicated for the
general factor of neuroticism and 111 for the anxiety/ten-
sion special factor with 14 genes being found to be asso-
ciated with both of these phenotypes. No other overlaps
occurring using eQTL mapping (Fig. 3e). Chromatin
interaction mapping indicated that 478 genes were impli-
cated in the general factor of neuroticism and 136 were
implicated for the anxiety/tension special factor, with 20
genes found to be shared between these two neuroticism
phenotypes. A total of 58 genes were implicated for the
worry/vulnerability special factor of neuroticism with 11 in
common with the general factor (Fig. 3f).
Finally, using MAGMA, eight genes were found to be
common in the 277 genes implicated for the general factor
of neuroticism and the 99 implicated for the anxiety/tension
special factor. A total of 65 genes were implicated for
worry/vulnerability, 20 of which were also associated with
the general factor of neuroticism and nine were found to
share an association with the anxiety/tension special factor.
No genes were found to be associated with all three phe-
notypes (Fig. 3g).
Of the 73 genes that were implicated as being linked to
the general factor of neuroticism by positional mapping,
eQTL mapping, and chromatin interaction mapping,
71 showed no overlap with either of the two special factors.
These genes that showed a unique association with the
general factor of neuroticism include MAPT, which encodes
the microtubule-associated protein tau. MAPT transcripts
are differentially expressed within the nervous system and
mutations in MAPT have been linked to neurodegenerative
disorders, such as Alzheimer’s disease, frontotemporal
dementia, and cortico-basal degeneration.
A total of 13 genes showed evidence of being linked to
the anxiety/tension special factor of neuroticism by the four
gene prioritization methods without being associated with
either the general factor of neuroticism or to the worry/
vulnerability special factor. Of these genes, DOC2A was of
note as it is mainly expressed in the brain and is involved in
Ca(2+)-dependent neurotransmitter release. Also, uniquely
associated with the anxiety/tension special factor was
BDNF (brain-derived neurotrophic factor), which encodes a
member of the nerve growth factor of proteins. The
expression of this gene has been found to be reduced in
those suffering from Alzheimer’s disease, Parkinson’s dis-
ease, and Huntington’s disease. BDNF has also been
implicated in the regulation of the stress response as well as
the biology of mood disorders. There were also ﬁve unique
genetic associations with the worry/vulnerability special
factor that were identiﬁed using the four methods of
prioritising genes. GRM8 (Glutamate metabotropic receptor
8) was one such gene and is linked to G-protein coupled
receptor activity and group III metabotropic glutamate
receptor activity. GRM8 has been associated with
schizophrenia.
Genes mapped based on position Genes mapped based on eQTL Genes mapped based on Chromatin 
interaction
Genome wide significant genes 
identified using MAGMA
E F GD
General Factor of Neuroticism 
n = 742
Anxiety/Tension
n = 222
Worry/Vulnerability
n = 71
A B C
Fig. 3 Panel a, b, and c show Venn diagrams illustrating the overlap of
the genes indicated using positional mapping, eQTL mapping, chro-
matin interaction mapping, and the genome-wide signiﬁcant gene-
based statistics derived using MAGMA, conducted on the general
factor of neuroticism (a), the anxiety/tension special factor (b), worry/
vulnerability special factor (c). Panel d, e, f, and g use Venn diagrams
to examine the overlap in the genes implicated across the three neu-
roticism phenotypes using positional mapping (d), eQTL mapping (e),
chromatin interaction mapping (f), and the genome-wide signiﬁcant
gene-based statistics derived using MAGMA (g)
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Gene-set and gene-property analysis
Gene-set analysis provided further evidence that special
factors of anxiety/tension and worry/vulnerability had a
different underlying biology compared with the general
factor of neuroticism. Eight gene sets attained statistical
signiﬁcance for the general factor of neuroticism (Supple-
mentary Table 20), two of which, neurogenesis (gene-set
size= 13,56 genes, P= 6.16 × 10−8) and neuron spine
(gene-set size= 116 genes, P= 2.95 × 10−6), have been
found to be signiﬁcantly enriched for neuroticism pre-
viously using the sum-score method to derive a neuroticism
measure [15]. No gene sets were found to be enriched for
the anxiety/tension special factor (Supplementary Table 21).
Two gene sets were found to be signiﬁcant for the worry/
vulnerability special factor (Supplementary Table 22), high
voltage gated calcium channel activity (gene-set size= 10
genes, P= 1.14 × 10−6), and voltage gated calcium channel
complex (gene-set size= 39 genes, P= 4.03 × 10−6).
Using all 18,330 genes from the MAGMA analysis, a
gene-property analysis was conducted. The gene-property
analysis showed a signiﬁcant relationship between the
gene’s level of transcription in the brain and their level
of association with each of the three factors (general
factor P= 8.64 × 10−7, anxiety/tension special factor P=
9.06 × 10−8, worry/vulnerability special factor P=
1.06 × 10−7 (Supplementary Table 23-25). The direction of
effect indicated that the greater the level of association a
gene had with each of the three phenotypes, the greater its
level of expression in the brain. This relationship can be
seen to encompass multiple regions across the cortex
(Supplementary Table 26-28). A gene’s level of expression
within the brain in the early-mid prenatal period was pre-
dictive of its association with the general factor of neuro-
ticism (P= 0.004) and the worry/vulnerability special factor
(P= 0.001) (Supplementary Table 29–31). None of the age
group speciﬁc transcription groupings were signiﬁcant
(Supplementary Table 32-34).
Genetic correlations with cognitive, psychiatric,
socioeconomic status (SES), health, anthropometric,
and reproductive traits
Next, we examined the overlap between the genome-wide
polygenic signal of the three neuroticism factors with
health, anthropometric, SES, longevity, reproductive, and
well-being variables. Following FDR correction for multi-
ple comparisons [41], 20 of the 32 genetic correlations were
statistically signiﬁcant for the general factor of neuroticism,
21 of the 32 were signiﬁcant for the anxiety/tension special
factor, and 20 of the 32 were statistically signiﬁcant for the
worry/vulnerability special factor (Fig. 4 and Supplemen-
tary Table 35).
The general factor of neuroticism showed signiﬁcant
negative genetic correlations with the cognitive variables
(intelligence, rg=−0.23, P= 1.83 × 10−23, educational
attainment, rg=−0.28, P= 1.43 × 10−47). By contrast, the
anxiety/tension and the worry/vulnerability special factor
showed signiﬁcant positive genetic correlations with intel-
ligence (anxiety/tension, rg= 0.08, P= 0.002, worry/vul-
nerability, rg= 0.19, P= 4.12 × 10−13) and with educational
attainment (anxiety/tension, rg= 0.16, P= 6.86 ×10−13,
worry/vulnerability, rg= 0.25, P= 3.07 × 10−25).
Such contrasting ﬁndings were also evident when exam-
ining SES variables. The genetic variants associated with a
higher level of the general factor of neuroticism were asso-
ciated with a greater genetic risk for a lower household
income (rg=−0.39, P= 8.56 × 10−24) and living in an area
with a higher level of social deprivation (rg=−0.27, P=
5.18 × 10−10). On the other hand, the anxiety/tension and the
worry/vulnerability special factors showed signiﬁcant genetic
correlations in the opposite directions to the general factor of
neuroticism for household income (anxiety/tension rg = 0.15,
P= 0.0019, worry/vulnerability rg= 0.17, P= 2.22 × 10−4)
and living in an area with a lower level of social deprivation
(anxiety/tension rg = 0.31, P= 1.04 × 10−8, worry/vulner-
ability rg= 0.22, P= 7.94 × 10−5). This indicates that,
Fig. 4 Genetic correlations between the general factor of neuroticism,
the anxiety/tension special factor, the worry/vulnerability special factor
with 31 cognitive/socioeconomic/health traits. Colour indicates the
direction of the correlation and shade indicates the magnitude of the
correlation. Asterisk indicates statistical signiﬁcance after controlling
for 32 tests using FDR, and a dagger indicates nominal signiﬁcance
that did not withstand FDR correction. Both the social deprivation and
self-rated health phenotype had the scales reversed so that a greater
score reﬂected a greater level of self-rated health and higher socio-
economic status [9, 75]. ADHD attention-deﬁcit/hyperactivity dis-
order, ASD autism spectrum disorder, MDD major depressive disorder,
FEV1 forced expiratory volume in 1 second
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whereas neuroticism may be associated with lower SES, the
two special factors measured here appear to be associated with
advantages that, in turn, are associated with the acquisition of
wealth, and improved living conditions.
This difference between the genetic correlations derived
using the general factor and the worry/vulnerability and the
anxiety/tension special factors was also found for repro-
ductive traits. For age at ﬁrst birth, the anxiety/tension and
worry/vulnerability special factors were genetically corre-
lated with delaying childbirth (anxiety/tension rg= 0.28,
P= 2.88 × 10−16, worry/vulnerability rg= 0.25, P= 1.18 ×
10−13) and having fewer children (anxiety/tension rg=
−0.26, P= 1.07 × 10−8, worry/vulnerability rg=−0.12,
P= 0.004). On the other hand, the negative genetic corre-
lation found between the general factor of neuroticism and
the age of ﬁrst birth (rg=−0.26, P= 4.37 × 10−18) and the
positive genetic correlation found between the general fac-
tor and number of children (rg= 0.11, P= 0.005) indicate
that genetic variants that are associated with higher general
neuroticism are also associated with a lower age at ﬁrst birth
and having more children.
Self-rated health and longevity also showed this pattern
of results, whereby signiﬁcant genetic correlations were
identiﬁed for the three traits, but with the opposite direction
of effect between the general factor and the two special
factors. For the general factor, a negative genetic correlation
was found with longevity (rg=−0.18, P= 0.006), a nom-
inally signiﬁcant negative genetic correlation was found
with parents’ age at death (rg=−0.16, P= 0.049), and a
negative genetic correlation was found with self-rated
health (rg=−0.48, P= 1.55 × 10−22). For the anxiety/ten-
sion and worry/vulnerability special factors, positive genetic
correlations were found with parental longevity, (anxiety/
tension, rg= 0.16, P= 0.023; worry/vulnerability, rg=
0.21, P= 0.002) and with self-rated health (anxiety/tension,
rg= 0.15, P= 3.92 × 10−4; worry/vulnerability, rg= 0.15,
P= 1.16 × 10−4). This pattern of genetic correlations indi-
cates that the genetic variants associated with an increase in
both special factors are also associated with better self-rated
health, as well as longer life.
Importantly, there were also phenotypes where the genetic
correlations with each of the three factors of neuroticism
showed a consistent direction of effect. As one would expect,
this was observed for mental health variables, including
schizophrenia (general factor rg= 0.16, P= 1.22 × 10−8,
anxiety/tension rg= 0.28, P= 7.66 × 10−24, worry/vulner-
ability rg= 0.17, P= 4.77 × 10−10), major depressive dis-
order (general factor rg= 0.68, P= 1.28 × 10−17, anxiety/
tension rg= 0.21, P= 0.003, worry/vulnerability rg= 0.19,
P= 0.01), and anorexia nervosa (general factor rg= 0.14,
P= 1.87 × 10−6, anxiety/tension rg= 0.20, P = 9.63 ×
10−9, worry/vulnerability rg= 0.22, P= 1.05 × 10−12). A
consistent direction of effect was also observed for the
genetic correlations with subjective well-being (general
factor rg=−0.68, P= 2.75 × 10−71, anxiety/tension rg=
−0.15, P= 0.0004, worry/vulnerability rg=−0.27, P=
1.36 × 10−9). This consistent direction of effect indicates
that the directional changes seen with the other categories of
traits are not a product of how the special factors were
constructed, or a product of collider bias, as each of the
three factors measured using the same neuroticism scale
make independent contributions that are linked to worse
mental health.
The two special factors also showed unique genetic
correlations with other variables. In the case of anxiety/
tension, a positive genetic correlation was found with both
systolic (rg= 0.22, P= 1.94−6) and diastolic blood pressure
(rg= 0.19, P= 2.46 × 10−4), indicating that the genetic
burden for the anxiety/tension special factor is associated
with unique health problems not associated with the genetic
risk of high levels of worry/vulnerability.
Genetic prediction
Polygenic risk score analysis was ﬁrst used to replicate the
overall polygenic signal associated with the general factor of
neuroticism, and the two special factors into an independent
sample. Polygenic risk scores were created using each of the
three neuroticism phenotypes in UK Biobank in order to
predict each of the three neuroticism phenotypes in GS:
SFHS using ﬁve P-value thresholds. This led to 15 analyses
per neuroticism phenotype (i.e., the general factor of neu-
roticism in UK Biobank was used to predict a general factor
of neuroticism in GS:SFHS using ﬁve P-value cut offs, the
anxiety/tension special factor in GS:SFHS using ﬁve P-
value cut offs, and the worry/vulnerability special factor in
GS:SFHS using ﬁve P-value cut offs). In each of these sets
of 15 tests, the greatest amount of variance was explained
when the factor of neuroticism that was used to construct the
PGRS was the same as that being predicted. The PGRS for
the general factor of neuroticism explained between 1.42 and
2.22% of the phenotypic variance of general neuroticism,
but only explained between 0.16 and 0.22% of the anxiety/
tension special factor and between 0.04 and 0.18% of the
worry/vulnerability special factor (Supplementary Table 36).
This same pattern was seen when deriving polygenic risk
scores using the special factors. The special factor of
anxiety/tension predicted between 0.40 and 0.45% of the
special factor of anxiety/tension, but only between 0.16 and
0.33% of the general factor of neuroticism and between
0.24 and 0.39% of the worry/vulnerability special factor.
Finally, the worry/vulnerability special factor predicted
between 0.67 and 0.97% of worry/vulnerability, but only
between 0.15 and 0.44% of the general factor of neuroti-
cism and only 0.09 and 0.12% of the special factor of
anxiety/tension (Supplementary Table 36).
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Using polygenic risk scores we were able to predict
variance in a number of phenotypes that showed genetic
correlations with each of the three factors of neuroticism.
Predicting household income and intelligence in GS:SFHS
we ﬁnd that, when using the general factor of neuroticism to
derive the PGRS, the beta weights from each of the ﬁve
PGRS were negative and the PGRS with the greatest
explanatory power for income used a P-value cut-off of
0.05 predicting 0.26% of variance in household income
(Beta=−0.051, SE= 0.012, P= 3.16 × 10−5); for intelli-
gence, a P-value cut-off of 1 explained the most variance at
0.24% (Beta=−0.049, SE= 0.012, P= 2.54 × 10−5).
When constructing the PGRS using the two special factors,
positive beta weights were observed when predicting both
intelligence and income. For anxiety/tension, the PGRS
with the greatest explanatory power when predicting
household income used a P-value cut-off of 0.05 and
explained 0.09% of the variance (Beta= 0.030, SE= 0.012,
P= 0.015). When predicting intelligence using anxiety/
tension a P-value cut-off of 0.01 explained 0.03% of
intelligence (Beta= 0.016, SE= 0.012, P= 0.161).
Although this was not signiﬁcant, it is consistent with the
genetic correlations presented as, out of the three neuroti-
cism phenotypes, anxiety/tension has the smallest genetic
correlation with intelligence.
Polygenic prediction using the special factor of worry/
vulnerability showed that the P-value cut-off of 1 pre-
dicted the most variance, 0.06%, again with a positive
beta (Beta= 0.024, SE= 0.012, P= 0.47). For intelli-
gence, a P-value cut of 0.01 was the most predictive,
explaining 0.12% where a positive beta was observed
(Beta= 0.032, SE= 0.012, P= 0.006) (Supplementary
Table 36).
Discussion
Higher neuroticism has been shown to be associated with
worse physical and mental health, as well as a shorter
lifespan [6]. However, much research is based on measures
in which individual items on neuroticism scales are summed
[19] to generate a single overall score, a method that may
occlude the effects of the heterogeneous traits that make up
neuroticism. This study used a bifactor model to estimate
scores relating to a general neuroticism factor and to two
special factors of neuroticism. By quantifying the variance
that is common across each of the 12 items, a general factor
of neuroticism was identiﬁed and extracted. In addition to
the extraction of this general factor, two special factors were
identiﬁed, which we termed anxiety/tension and worry/
vulnerability. These special factors can be seen to measure
aspects of neuroticism that are independent from the general
factor and may be conceptualized as the aspects of
neuroticism that are uncorrelated with much of what is
typically measured in a neuroticism battery; nevertheless,
following the removal of variance that is common across all
12 items, they are still related to a subset of the neuroticism
items. Anxiety/tension, therefore, is primarily composed of
the residual variance from three items (“Would you call
yourself a nervous person?”, “Would you call yourself tense
or ‘highly strung’?”, “Do you suffer from ‘nerves’?”) that
provide a measure of how nervous or tense a person is after
the variance that is common across each of the 12 items is
removed. As such, this special factor can be thought of as
the degree to which an individual is anxious and tense given
their overall level of neuroticism. Mutatis mutandis, the
worry/vulnerability special factor can be interpreted in a
similar manner. Both of these special factors were inde-
pendent of the general factor.
Previous attempts to examine the heterogeneity of neu-
roticism using the UK Biobank data have used the sum-
score approach, following the identiﬁcation of items that are
more strongly genetically correlated with each other [19].
However, although sub-factor scores derived in this way
will contain variance speciﬁc to the sub-factor, they will
also be contaminated with, depending on the items summed,
a considerable amount of variance attributable to the general
factor of neuroticism. This known issue [60] can seen in the
work of Nagel et al. [19] who found that the genetic cor-
relations between the depressed affect and worry sub-fac-
tors, with a general neuroticism factor were 0.86 and 0.84,
respectively. Clearly, then, little can emerge from the
‘speciﬁc’ item-clusters of Nagel et al. [19] that is not, in
fact, relevant to general neuroticism.
The sub-factor of worry in Nagel et al. [19] is a sum-
score of the neuroticism items of “Would you call your-
self a nervous person?”, “Are you a worrier?”, “Would
you call yourself tense or ‘highly strung’?”, and “Do you
suffer from ‘nerves’?”. In the current study we found that,
independent of the variance that they shared with all 12
items, i.e., the general factor variance, the ﬁrst, third, and
fourth of these items loaded most strongly onto the
anxiety/tension special factor identiﬁed by Gale et al. [6].
By comparing Fig. 3 of Nagel et al. [19] with Fig. 4 of the
current study, one can see the effect that contamination
from a general factor of neuroticism has. For example,
Nagel et al. [19] found negative genetic correlations with
intelligence (which they referred to as IQ) and with edu-
cation, using their sum-score phenotype/item-cluster of
“worry”; in the current study, however, the variation
unique to being anxious and tense has a positive genetic
correlation with both of these phenotypes. We also show a
protective effect for genes that underlie individual dif-
ferences in this factor, as they are associated with longer
life and a reduced risk of coronary artery disease, in
contrast to the ﬁndings of Nagel et al. [19].
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Genome-wide association studies conducted on the
general factor of neuroticism and the two special factors
indicate that these are genetically heterogeneous traits at the
SNP, gene, and biological pathway level. In addition,
genetic correlations indicate that these phenotypes, derived
using the same neuroticism scale, have distinct genetic
etiologies that show a different overlap with health, cogni-
tive, SES, reproductive, and anthropometric traits.
For the general factor of neuroticism, 51 independent
genomic loci were identiﬁed, consistent with the original
analysis of the UK Biobank data by Luciano et al. [15]
and the re-analysis of the Luciano et al. [15] data sets by
Nagel et al. [17], both of which used a sum-score measure
of neuroticism. For the two special factors, fewer loci
were identiﬁed, with 14 being associated with anxiety/
tension and 10 for worry/vulnerability. Although there
was very little overlap in these loci, functional annotation
for each of these phenotypes produced highly similar
results where independent genomic loci contained SNPs
that were predominantly found in introns, and intergenic
regions. This is in line with ﬁndings from GWAS con-
ducted on other traits [9, 61] where the SNPs with the
greatest effect were found in regions of the genome that
are involved in gene expression, rather than in protein
coding regions.
More similarity in the genetic etiology of these three
neuroticism traits was seen when examining the relationship
between gene expression in particular tissues and the gene-
based test association statistics from MAGMA. In the cur-
rent study, a gene’s level of expression in the brain was
predictive of its association with each of the three pheno-
types, a relationship that was found across the cortex. This
indicates that common genetic variation in genes that are
predominantly expressed in the brain are associated with
each of the three neuroticism phenotypes.
Despite the similarity of the functional annotation of
each of the three neuroticism phenotypes, there was a high
level of divergence regarding which genes may be causal in
these associations. As can be seen in Fig. 3a-c (and in
Supplementary Figures 1-3), 104 genes were identiﬁed as
possible causal genes underlying the associations found for
the general factor using genomic position, eQTL informa-
tion, and chromatin interaction data. Using the same
methods, 24 genes were identiﬁed as potentially harbouring
causal variation for the anxiety/tension special factor, and
ﬁve genes for the worry/vulnerability special factor. The
genes that were implicated for each of the three phenotypes
showed very little overlap (Fig. 3d–f). This lack of overlap
is also seen when examining the gene-based statistics,
which also show that while a large number of genes were
implicated, only a small number were implicated across two
neuroticism phenotypes, with no genes being implicated
across all three.
This lack of overlap in the genes implicated as being
causally linked to the general factor of neuroticism and both
the anxiety/tension and worry/vulnerability special factors
indicates a divergent biology across the three neuroticism
phenotypes. However, on examination of the genes that are
unique to each of the three neuroticism phenotypes, it is
clear that many have been linked to the activity and/or
structure of the brain or are implicated in pathology that
effects cortical tissues. For the anxiety/tension special fac-
tor, this included DOC2A and BDNF, which were both
implicated using positional mapping, eQTL analysis, chro-
matin analysis, and gene-based statistics derived using
MAGMA. DOC2A is mainly expressed in the brain and
thought to be linked to Ca(2+)-dependent neurotransmitter
release and has been previously linked to schizophrenia
[62], a psychiatric disorder, in part, characterized by dis-
orded cognitive functioning. Also linked to the anxiety/
tension special factor was BDNF, which is also pre-
dominantly expressed in the brain and encodes a nerve
growth factor and the binding of this protein to its receptor
and promotes neuronal survival. Expression of BDNF has
also been found to be reduced in patients with Alzheimer’s
disease, Parkinson’s disease, and Huntington’s disease
indicating its importance the healthy adult brain.
Although, for the worry/vulnerability special factor, only
ﬁve genes were uniquely implicated using all four gene-
ﬁnding strategies, the GRM8 gene was among them. GRM8,
like DOC2A, has been linked to schizophrenia in addition to
sporadic Creutzfeldt–Jakob disease risk [63]. The GRM8
gene codes for the protein mGluR8 that belongs to the
metabotropic glutamate receptor family. This family has
been associated with the transduction of physiological and
cytotoxic signals mediated by the prion protein (PrPC).
Other members of the metabotropic glutamate receptor
family, mGluR1 and mGluR5, have been shown to interact
with PrPC and these associations appear to facilitate neurite
outgrowth [64, 65]. Furthermore, it has been demonstrated
that mGluR5 coupled with PrPC mediates the cellular
toxicity of soluble β-amyloid oligomers [65].
More biological differences were seen between the three
neuroticism phenotypes when looking at the results of the
gene-set analysis. For the general factor, eight gene sets
were statistically signiﬁcant once controlling for multiple
tests. Of these eight, none were nominally signiﬁcant for the
anxiety/tension special factor, and, although four were
nominally signiﬁcant for the worry/vulnerability special
factor, this did not withstand correction for multiple tests.
The gene-set of neurogenesis was the most signiﬁcant gene-
set that was uniquely associated with the general factor of
neuroticism. This result is consistent with what was found
using a sum-score approach [14].
Neurogenesis is the process by which new neurons are
created and this processes has previously been linked to
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intelligence in humans using GWAS data [9], and has been
linked to cognitive ﬂexibility in rodent models of cognitive
ability [66–72]. This shared association between neuro-
genesis with both neuroticism and intelligence is unique to
the general factor of neuroticism and, may serve to provide
a partial explanation of the genetic correlation between
intelligence, neuroticism, and mental health [73].
Two gene sets were also statistically signiﬁcant for the
worry/vulnerability special factor (high voltage gated cal-
cium channel activity and the voltage gated calcium channel
complex). These were unique associations with no nominal
level of association being found with either the general
factor or with the anxiety/tension special factor. Voltage
gated calcium channels act as transducers of cell surface
membrane potential changes into transient intracellular
calcium that serves to initiate many kinds of physiological
events. This temporary inﬂux of calcium in response to
membrane depolarisation serves to regulate many intracel-
lular processes including neurotransmission and gene
expression [74].
The results of the GWAS, its functional annotation, as
well as the gene-based statistics, the gene-set and gene-
property analyses, indicate that these neuroticism pheno-
types are linked together regarding the greatest signal being
found in regions of the genome involved in gene expres-
sion, and the total underlying polygenic signal clustering in
genes that are predominately expressed in and across the
brain. However, these phenotypes diverge when consider-
ing which genes are linked to the independent genomic loci,
the genes that are mapped to them and which biological
systems within the brain are implicated.
The pattern of genetic correlations seen with other phe-
notypes supports the ﬁndings that neuroticism, as derived
using a sum-score method, is composed of multiple
genetically heterogeneous phenotypes that have different
genetic relationships to health, disease, and SES. This can
most clearly be seen when examining the genetic correla-
tions derived using cognitive, SES, longevity, and repro-
ductive traits. As seen in Fig. 4, the general factor of
neuroticism shows sizable negative genetic correlations
with cognitive, SES, longevity, and reproductive traits (with
the exception of number of children that displays a positive
genetic correlation), whereas worry/vulnerability and anxi-
ety/tension both show positive genetic correlations (with the
exception of number of children that displays a negative
genetic correlation). This indicates that the genetic risk for
higher levels of the general factor of neuroticism is asso-
ciated with an increased genetic risk of lower intelligence,
lower levels of education, a lower level of SES, an earlier
death, and more children being born at earlier ages,
whereas the genetic variants linked with worry/vulnerability
and anxiety/tension are linked to the genetic variants that
facilitate intelligence, education, SES, are linked to a longer
life, with fewer children being born, and giving birth at an
older age.
Other traits from outside these categories display this
same pattern, whereby the genetic risk for coronary artery
disease is linked to the genetic risk for higher levels of
general neuroticism but lower levels of anxiety/tension and
worry/vulnerability. This reversal of the direction of effect
is also seen when comparing genetic correlations derived
from the general factor of neuroticism to those derived
using the two special factors for self-rated health, smoking,
and ADHD.
The general factor of neuroticism showed the strongest
genetic correlations with major depressive disorder and
subjective well-being. The magnitude of these genetic cor-
relations (≥0.65), indicates a substantial genetic overlap. Of
note is that the two special factors of neuroticism both
display genetic correlations with major depressive disorder
and subjective well-being that are in the same direction as
those found using the general factor of neuroticism. This
ﬁnding suggests that, in addition to a general factor of
neuroticism, there are two sources of structured variance,
indicating the presence of genetically heterogeneous phe-
notypes, also measured using a neuroticism scale. All three
of these neuroticism phenotypes contribute independently
to major depressive disorder, and to subjective well-being.
A consistent direction of effect was also observed for
schizophrenia with positive genetic correlations identiﬁed
for each of the three neuroticism phenotypes. In contrast to
the genetic correlations with MDD and subjective well-
being, the genetic correlation of the greatest magnitude was
not with the general factor of neuroticism, but with the
special factor of anxiety/tension (Fig. 4.). This indicates that
much of the genetic link between schizophrenia and neu-
roticism is separate from what is common across the items
used to measure neuroticism, and is best captured, not only
by a subset of items, but also by a subset of the variance
remaining once the variance that is common across all 12
items is removed.
Using polygenic risk scores we were able to show that
the polygenic signal associated with the general factor of
neuroticism, and each of the special factors, replicated into
an independent sample. This can be seen as polygenic risk
scores predicting the general factor of neuroticism in GS:
SFHS, had the greatest explanatory power when derived
using the general factor of neuroticism in UK Biobank. This
pattern was also found for the two special factors where the
special factor of anxiety/tension explained the most var-
iance for the special factor of anxiety/tension, and the
special factor of worry/vulnerability explained the most
variance for the special factor of worry/vulnerability. This
shows that the polygenic signal associated with each of the
special factors is a better match to the same special factor
derived an independent cohort, and not, as would be
W. D. Hill et al.
predicted if our factors were contaminated by variance
associated with the general factor [19], simply another
measure of general neuroticism.
The protective aspects of the polygenic signal associated
with each of the special factors of anxiety/tension and
worry/vulnerability was also replicated into GS:SFHS. This
replication can be seen in that the polygenic burden for the
general factor of neuroticism is predictive of lower SES, as
measured using household income, and lower intelligence,
whereas the polygenic burden for each of the special factors
is associated with an increase in SES and intelligence.
Neuroticism is one of the most well-studied personality
traits in the psychology and health literature, and it has been
recognized as an important risk factor for personal, societal
and ﬁnancial woes in human societies [7]. The present work
develops ﬁndings of neuroticism at the level of the pheno-
type [6, 35] by showing that neuroticism is ‘molecular’ and
not ‘atomic’ at the genetic level also, with differently-
valenced ‘atoms’ on these ‘molecules’ being related to both
better and poorer human functioning.
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